Approval · Notice of Compliance 16557 · 2015
LIPIDIL MICRO: Notice of Compliance 16557
Issued January 23, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16557
- Date
- January 23, 2015
- Company
- Abbott Products Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
- Therapeutic class
- Lipid metaboloism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LIPIDIL MICRO | 02146959 | Cancelled Post Market |
Medicinal ingredients
- FENOFIBRATE 200 MG per CAP